Waters Corporation (WAT)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
394.85-7.26 (-1.81%)
As of 11:55AM EDT. Market open.
| Previous close | 402.11 |
| Open | 399.81 |
| Bid | 394.34 x 800 |
| Ask | 394.67 x 800 |
| Day's range | 391.57 - 399.27 |
| 52-week range | 188.22 - 428.22 |
| Volume | 85,610 |
| Avg. volume | 344,570 |
| Market cap | 24.229B |
| Beta (5Y monthly) | 0.80 |
| PE ratio (TTM) | 37.32 |
| EPS (TTM) | 10.58 |
| Earnings date | 25 Oct 2021 - 29 Oct 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 26 Nov 1996 |
| 1y target est | 361.75 |
- Simply Wall St.
Waters Corporation's (NYSE:WAT) Intrinsic Value Is Potentially 26% Below Its Share Price
How far off is Waters Corporation ( NYSE:WAT ) from its intrinsic value? Using the most recent financial data, we'll...
- Business Wire
Waters BioAccord System with ACQUITY Premier Brings Greater Simplicity, Accuracy and Reproducibility to Multi-Attribute Monitoring of Biopharmaceuticals
MILFORD, Mass., September 16, 2021--The BioAccord System with ACQUITY Premier simplifies CQA monitoring of biologics by improving analyte recovery and assay-to-assay reproducibility.
- Zacks
Waters (WAT) BioAccord System to Expand Portfolio Offerings
Waters (WAT) introduces Waters BioAccord System with ACQUITY Premier for seamless monitoring of attributes of biotherapeutics.
© 2021 Verizon Media. All rights reserved.
